Fibroblast growth factor receptor (FGFR) inhibitor rogaratinib in patients with advanced pretreated squamous-cell non-small cell lung cancer over-expressing FGFR mRNA: The SAKK 19/18 phase II study
JOURNAL OF CLINICAL ONCOLOGY（2022）
摘要
•Rogaratinib failed to improve PFS in patients with advanced squamous lung cell carcinomas overexpressing FGFR mRNA.
更多查看译文
关键词
SQCLC,FGFR inhibitor
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要